105 related articles for article (PubMed ID: 26821819)
1. 4H-Thieno[3,2-c]chromene based inhibitors of Notum Pectinacetylesterase.
Han Q; Pabba PK; Barbosa J; Mabon R; Healy JP; Gardyan MW; Terranova KM; Brommage R; Thompson AY; Schmidt JM; Wilson AG; Xu X; Tarver JE; Carson KG
Bioorg Med Chem Lett; 2016 Feb; 26(4):1184-7. PubMed ID: 26821819
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase.
Tarver JE; Pabba PK; Barbosa J; Han Q; Gardyan MW; Brommage R; Thompson AY; Schmidt JM; Wilson AGE; He W; Lombardo VK; Carson KG
Bioorg Med Chem Lett; 2016 Mar; 26(6):1525-1528. PubMed ID: 26897593
[TBL] [Abstract][Full Text] [Related]
3. 5-Phenyl-1,3,4-oxadiazol-2(3
Mahy W; Willis NJ; Zhao Y; Woodward HL; Svensson F; Sipthorp J; Vecchia L; Ruza RR; Hillier J; Kjær S; Frew S; Monaghan A; Bictash M; Salinas PC; Whiting P; Vincent JP; Jones EY; Fish PV
J Med Chem; 2020 Nov; 63(21):12942-12956. PubMed ID: 33124429
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibitors of carboxylesterase Notum.
Zhao Y; Jolly S; Benvegnu S; Jones EY; Fish PV
Future Med Chem; 2021 Jun; 13(11):1001-1015. PubMed ID: 33882714
[TBL] [Abstract][Full Text] [Related]
5. Structural Insights into Notum Covalent Inhibition.
Zhao Y; Svensson F; Steadman D; Frew S; Monaghan A; Bictash M; Moreira T; Chalk R; Lu W; Fish PV; Jones EY
J Med Chem; 2021 Aug; 64(15):11354-11363. PubMed ID: 34292747
[TBL] [Abstract][Full Text] [Related]
6. Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Bayle ED; Svensson F; Atkinson BN; Steadman D; Willis NJ; Woodward HL; Whiting P; Vincent JP; Fish PV
J Med Chem; 2021 Apr; 64(8):4289-4311. PubMed ID: 33783220
[TBL] [Abstract][Full Text] [Related]
7. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity.
Steadman D; Atkinson BN; Zhao Y; Willis NJ; Frew S; Monaghan A; Patel C; Armstrong E; Costelloe K; Magno L; Bictash M; Jones EY; Fish PV; Svensson F
J Med Chem; 2022 Jan; 65(1):562-578. PubMed ID: 34939789
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum.
Zhao Y; Ren J; Hillier J; Jones M; Lu W; Jones EY
J Pineal Res; 2020 Mar; 68(2):e12630. PubMed ID: 31876313
[TBL] [Abstract][Full Text] [Related]
9. Caffeine inhibits Notum activity by binding at the catalytic pocket.
Zhao Y; Ren J; Hillier J; Lu W; Jones EY
Commun Biol; 2020 Oct; 3(1):555. PubMed ID: 33033363
[TBL] [Abstract][Full Text] [Related]
10. The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: the first clinical candidate.
Wang JL; Carter J; Kiefer JR; Kurumbail RG; Pawlitz JL; Brown D; Hartmann SJ; Graneto MJ; Seibert K; Talley JJ
Bioorg Med Chem Lett; 2010 Dec; 20(23):7155-8. PubMed ID: 21055613
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Doshi JM; Tian D; Xing C
J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
[TBL] [Abstract][Full Text] [Related]
13. Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities.
Perspicace E; Cozzoli L; Gargano EM; Hanke N; Carotti A; Hartmann RW; Marchais-Oberwinkler S
Eur J Med Chem; 2014 Aug; 83():317-37. PubMed ID: 24974351
[TBL] [Abstract][Full Text] [Related]
14. Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors.
Wu WL; Asberom T; Bara T; Bennett C; Burnett DA; Clader J; Domalski M; Greenlee WJ; Josien H; McBriar M; Rajagopalan M; Vicarel M; Xu R; Hyde LA; Del Vecchio RA; Cohen-Williams ME; Song L; Lee J; Terracina G; Zhang Q; Nomeir A; Parker EM; Zhang L
Bioorg Med Chem Lett; 2013 Feb; 23(3):844-9. PubMed ID: 23265892
[TBL] [Abstract][Full Text] [Related]
15. Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
Willis NJ; Mahy W; Sipthorp J; Zhao Y; Woodward HL; Atkinson BN; Bayle ED; Svensson F; Frew S; Jeganathan F; Monaghan A; Benvegnù S; Jolly S; Vecchia L; Ruza RR; Kjær S; Howell S; Snijders AP; Bictash M; Salinas PC; Vincent JP; Jones EY; Whiting P; Fish PV
J Med Chem; 2022 May; 65(10):7212-7230. PubMed ID: 35536179
[TBL] [Abstract][Full Text] [Related]
16. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life.
Wang JL; Limburg D; Graneto MJ; Springer J; Hamper JR; Liao S; Pawlitz JL; Kurumbail RG; Maziasz T; Talley JJ; Kiefer JR; Carter J
Bioorg Med Chem Lett; 2010 Dec; 20(23):7159-63. PubMed ID: 20709553
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase.
Mountford SJ; Albiston AL; Charman WN; Ng L; Holien JK; Parker MW; Nicolazzo JA; Thompson PE; Chai SY
J Med Chem; 2014 Feb; 57(4):1368-77. PubMed ID: 24471437
[TBL] [Abstract][Full Text] [Related]
18. The optimization of pyridazinone series of glucan synthase inhibitors.
Kuang R; Wu H; Ting PC; Aslanian RG; Cao J; Kim DW; Lee JF; Schwerdt J; Zhou G; Herr RJ; Zych AJ; Yang J; Lam SQ; Jenkins DM; Sakwa SA; Wainhaus S; Black TA; Cacciapuoti A; McNicholas PM; Xu Y; Walker SS
Bioorg Med Chem Lett; 2012 Aug; 22(16):5268-71. PubMed ID: 22818082
[TBL] [Abstract][Full Text] [Related]
19. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: the three microdose candidates.
Wang JL; Aston K; Limburg D; Ludwig C; Hallinan AE; Koszyk F; Hamper B; Brown D; Graneto M; Talley J; Maziasz T; Masferrer J; Carter J
Bioorg Med Chem Lett; 2010 Dec; 20(23):7164-8. PubMed ID: 20728356
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
